Combined gemfibrozil (peroxisome proliferator-activated receptor alpha agonist) with reduced steroid dose gives a similar management picture as the full steroid dose in a rat adjuvant-induced arthritis model. Issue 4 (4th July 2019)
- Record Type:
- Journal Article
- Title:
- Combined gemfibrozil (peroxisome proliferator-activated receptor alpha agonist) with reduced steroid dose gives a similar management picture as the full steroid dose in a rat adjuvant-induced arthritis model. Issue 4 (4th July 2019)
- Main Title:
- Combined gemfibrozil (peroxisome proliferator-activated receptor alpha agonist) with reduced steroid dose gives a similar management picture as the full steroid dose in a rat adjuvant-induced arthritis model
- Authors:
- Ashour, Hend
Rashed, Laila Ahmed
El-Sebaie, Mohamed Mahmoud
Sabry, Marwa Mohammed
Abdelmohsen, Manal Ali
Eissa, Mervat - Abstract:
- Abstract: Objectives: The study aimed to evaluate the efficacy of combined gemfibrozil with prednisolone in the management of adjuvant-induced arthritis (AIA) rat model. Methods: Seventy two adult male Wistar albino rats were divided equally into 1-control group, three diseased groups: 2- Adjuvant induced arthritis (AIA), 3- high fat diet (HF), and 4- combined AIA-HF, and treated groups: 5- gemfibrozil 30 mg/kg treated AIA group (AIA-G) and the combined AIA-HF treated groups: 6- prednisolone equivalent to human 10 mg (AIA-HF-P10), 7- prednisolone equivalent to human 5 mg (AIA-HF-P5) 8- gemfibrozil (HF-AIA-G) and 9- combined treatment (HF-AIA-G-P5) Results: HF diet represents a precipitating factor for knee arthritis. Gemfibrozil improved the inflammatory findings in both AIA and AIA-HF groups. Combined administration of gemfibrozil with reduced steroid dose gave a similar therapeutic effect to the full steroid dose. Fortunately, we reported more reduction in the nuclear factor kappa-B (NF-κB) and high mobility group box 1 (HMGB1) in the HF-AIA-G-P5 compared with the HF-AIA-P10 group. The improvement was proved by the histological findings. Conclusion: Combined reduced prednisolone dose with gemfibrozil potentiates its anti-inflammatory activity. This could be a target in the management of rheumatoid arthritis.
- Is Part Of:
- Modern rheumatology. Volume 29:Issue 4(2019)
- Journal:
- Modern rheumatology
- Issue:
- Volume 29:Issue 4(2019)
- Issue Display:
- Volume 29, Issue 4 (2019)
- Year:
- 2019
- Volume:
- 29
- Issue:
- 4
- Issue Sort Value:
- 2019-0029-0004-0000
- Page Start:
- 602
- Page End:
- 611
- Publication Date:
- 2019-07-04
- Subjects:
- Gemfibrozil -- Pparα -- rheumatoid arthritis -- steroid
Rheumatology -- Periodicals
616.723005 - Journal URLs:
- http://firstsearch.oclc.org ↗
https://academic.oup.com/mr ↗
https://www.tandfonline.com/journals/imor20 ↗
http://informahealthcare.com/loi/mor ↗
http://link.springer-ny.com/link/service/journals/10165/index.htm ↗
http://link.springer.com/journal/10165 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/14397595.2018.1508800 ↗
- Languages:
- English
- ISSNs:
- 1439-7595
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5895.300000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23808.xml